Medication-Assisted Weight Loss

Benefits

• Clinically meaningful weight loss
• Improved cardiometabolic markers like blood pressure, A1C, and cholesterol
• Non-surgical, with zero downtime
• Can make physical activity easier and more enjoyable, reinforcing healthy habits

Limitations

• Nausea and gastrointestinal side effects are common
• Insurance coverage is unlikely if you do not have diabetes or meet certain conditions
• Long-term therapy of a year or more is usually required to achieve your goals; discontinuation often leads to partial or complete regain

A1C (Hemoglobin A1C): A blood test that estimates average blood sugar over about three months and helps track metabolic health during treatment.

Adherence: How consistently you follow your prescribed dosing and lifestyle plan, which strongly influences results.

Adipose Tissue: Body fat that these medications help reduce by lowering appetite and improving metabolic signals.

Adverse Effects: Unintended symptoms like nausea, vomiting, constipation, or diarrhea that are usually mild and improve with dose titration.

Appetite Suppression: A reduced drive to eat, caused by medication effects on hunger and satiety centers in the brain.

Baseline Labs: Initial blood tests—such as A1C, lipids, kidney and liver function—used to guide safe treatment and monitor progress.

BMI (Body Mass Index): A height-to-weight ratio used to screen eligibility for anti-obesity medications.

Body Composition: The proportion of fat mass and lean mass in your body, which guides protein goals and resistance training to protect muscle.

Cardiometabolic Risk: The combined risk of heart disease and metabolic conditions that often decreases with weight loss.

Constipation: A common, usually temporary side effect managed with hydration, fiber, activity, and sometimes gentle stool softeners.

Contraindication: A condition that makes a treatment unsafe.

Delayed Gastric Emptying: Slower movement of food from the stomach that helps you feel full longer but can increase reflux or nausea.

Dose Escalation (Titration): Gradually increasing the dose over weeks to improve tolerance and reduce side effects.

Dose Plateau: The point where your maintenance dose stays steady for continued benefit with fewer side effects.

Dyspepsia: Indigestion or upper-abdominal discomfort that may occur early in treatment and typically lessens with time.

Eligibility Criteria: Medical guidelines for starting therapy, commonly BMI ≥ 30 or ≥ 27 with a weight-related condition.

Electrolytes: Blood salts like sodium and potassium that can shift with dehydration from vomiting or diarrhea.

GLP-1 Receptor Agonist: A medication that mimics the GLP-1 hormone to increase fullness, slow gastric emptying, and aid weight loss.

Glycemic Control: How steadily your blood sugar stays in a healthy range, which often improves on these medications.

Heartburn (Reflux): A burning chest sensation that can occur with delayed gastric emptying.

Incretin Hormones: Natural gut hormones (GLP-1 and GIP) that signal fullness, enhance insulin, and reduce appetite after meals.

Injection Site Reaction: Redness, itching, or tenderness where medicine is injected that usually resolves quickly.

Insulin Resistance: Reduced response to insulin that improves with weight loss and therapy.

Insurance Prior Authorization: Approval required by insurers before covering medication costs, often requiring documentation of eligibility.

Interruption and Retitration: Restarting at a lower dose after missed doses or illness to reduce side effects.

Lean Mass: Muscle and other non-fat tissues that we aim to preserve with adequate protein intake and resistance exercise during weight loss.

Lifestyle Adjunct: The diet, activity, sleep, and stress habits that support medication results and long-term maintenance.

Long-Acting Medication: A formulation designed for once-weekly dosing to keep levels steady.

Maintenance Dose: The ongoing dose you continue after titration that balances benefits and tolerability.

Medullary Thyroid Carcinoma (MTC): A rare thyroid cancer that is a key contraindication to these medications.

MEN2 (Multiple Endocrine Neoplasia Type 2): A genetic syndrome that increases thyroid cancer risk and is a contraindication to therapy.

Muscle Loss (Sarcopenia): Unwanted loss of lean mass during weight loss, minimized by protein intake and strength training.

Nausea: A common early side effect that often improves by eating smaller, slower, and lower-fat meals.

Nutritional Counseling: Professional guidance on protein targets, fiber, hydration, and meal structure to optimize results.

Off-Label Use: Prescribing a medication for a purpose not specifically listed on its label when supported by clinical judgment.

Pancreatitis: Inflammation of the pancreas signaled by severe, persistent upper-abdominal pain; stop medication and seek care if suspected.

Perioperative Hold: Temporarily pausing medication before anesthesia or sedation due to delayed gastric emptying.

Plateau (Weight-Loss Plateau): A period when weight stabilizes despite continued treatment, often addressed by habit tuning or dose adjustment.

Protein Target: A daily protein goal that helps preserve muscle and reduce hunger during weight loss.

Rebound Weight Gain: Regain that can occur after stopping medication without a maintenance plan; gradual taper and lifestyle skills help prevent it.

Renal Impairment: Reduced kidney function that warrants careful hydration and monitoring when using these medications.

Retitration (After Missed Doses): Stepping back to a previously tolerated dose to restart safely after an interruption.

Satiety: The sensation of fullness that helps reduce calorie intake and snacking.

Semaglutide: A GLP-1 receptor agonist used for chronic weight management and glycemic control.

Subcutaneous Injection: A shallow injection into the fat layer of the abdomen, thigh, or upper arm.

Telogen Effluvium: Temporary hair shedding that can follow rapid weight loss and typically resolves as nutrition stabilizes.

Tirzepatide: A dual GIP/GLP-1 receptor agonist used to reduce appetite and improve metabolic markers.

Titration Schedule: The planned stepwise dose increases used to build tolerance and effectiveness.

Weekly Dosing: A once-weekly medication schedule that improves convenience and adherence for many patients.